In Investor or Pr Presenta tati tion on. We simply grow - - PowerPoint PPT Presentation

in investor or pr presenta tati tion on
SMART_READER_LITE
LIVE PREVIEW

In Investor or Pr Presenta tati tion on. We simply grow - - PowerPoint PPT Presentation

In Investor or Pr Presenta tati tion on. We simply grow better. The The Sup Supreme Canna nnabis Company ny T S X : F I R E 1 reasonable in the circumstances. However, the Company accessed under the Companys profile on the System


slide-1
SLIDE 1

The The Sup Supreme Canna nnabis Company ny T S X : F I R E

1

In Investor

  • r

Pr Presenta tati tion

  • n.

We simply grow better.

slide-2
SLIDE 2

2

Di Discl claimer. mer.

Certain information regarding The Supreme Cannabis Company, Inc. (“Supreme” or the “Company”) contained herein may constitute forward-looking statements within the meaning of applicable securities laws and or be subject to change without notice. Forward-looking statements may include estimates, plans, expectations,

  • pinions, forecasts, projections, guidance or other

statements that are not statements of fact. Forward- looking statements are current as of the date they are made and are based on applicable estimates and assumptions made by us at the relevant time in light of our experience and perception of historical trends, current conditions and expected future developments, as well as

  • ther factors that we believe are appropriate and

reasonable in the circumstances. However, the Company does not undertake to update any such forward-looking information whether as a result of new information, future events or otherwise, except as required under applicable securities laws in Canada. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward- looking statements because the Company can give no assurance that they will prove to be correct. Many factors could cause our actual results, level of activity, performance or achievements or future events or developments to differ materially from those expressed or implied by the forward-looking statements, including, without limitation, the factors discussed in the “Risk Factors” section of the Company’s Annual Information Form dated October 2, 2018 (“AIF”). A copy of the AIF and the Company’s other publicly filed documents can be accessed under the Company’s profile on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com. The Company cautions that the list of risk factors and uncertainties described in the AIF is not exhaustive and other factors could also adversely affect its

  • results. Certain industry data contained in this

presentation have been obtained from third party sources and the Company has not independently verified any of the data from third party sources nor it ascertained the underlying assumptions relied upon therein, or whether such data has changed since the date thereof. The Company’s forward-looking statements are expressly qualified in their entirety by this cautionary statement.

slide-3
SLIDE 3

3

Use our kn know

  • wledge

edge of

  • f

the the plant nt to create tr transfo nsformati tive ve br brands that deliver po positive expe peri rience ces.

We We Simply imply Gro Grow B Bet etter. er.

slide-4
SLIDE 4

4

  • 600+ employees
  • 440,000 sqft cultivation facility Kincardine, ON
  • Sales, processing and cultivation licenses
  • 34,000 sqft research and development facility to be

built in Goderich, ON

  • Commenced applications for cultivation license
  • 400+ employees
  • Produces cannabis oil from facility in Lesotho
  • Cultivation, extraction and processing licenses

Fr From he headqua uarters in n Toront nto, ON, +60 employees provi vide corporate servi vices to the he company ny’s bus usine nesses, inve nvestment nts and nd partner ers: :

  • 30+ employees
  • 12,000 sqft facility in Langley, BC
  • Processing and sales license for cannabis oils

(expected Q3 2019)

Exclusive agreement to launch premium cannabis products Partnership to enter vaporizer market with 7ACRES oil pods

Legal & Regulatory Government Relations Information Technology Sales & Marketing Corporate Development

Partnerships. Businesses and Investments. Supreme Cannabis.

Finance

  • Headquartered in London, UK
  • Targets investment opportunities in CBD health

and wellness businesses in the UK and Europe

  • 5,000 sqft Health Canada licensed facility in Ontario
  • Europe operations selling CBD Hemp products into

the UK and Netherlands

slide-5
SLIDE 5

5

Establish fo foundational IP IP and st stron rong core

  • re

bu busin ines esses es. Create di differentiat ated d co consumer-dr driven pr produ duct cts across market segments. Expand consumer- centric approach to in inte ternatio tional l marke kets ts.

Su Supre reme me Ca Cannabis bis’ approa roach ch. 1. 1. 2. 2. 3. 3.

CONSUMER-DRIVEN BRANDS THAT DELIVER PREMIUM PRODUCTS.

slide-6
SLIDE 6

10

6

18

Establish fo foundational IP IP and st stron rong core

  • re

bu busin ines esses es. Create di differentiat ated d co consumer-dr driven pr produ duct cts across market segments. Expand consumer- centric approach to in inte ternatio tional l marke kets ts.

1. 1. 2. 2. 3. 3.

slide-7
SLIDE 7

Number of new cannabis users doubled year over

  • year. By 2023, the legal

Canadian cannabis market is expected to reach $6.7 billion1.

Pr Promi

  • mising

Ca Canadian Market.

Government-controlled wholesale and distribution combined with long-term domestic protection from imports.

Pr Prot

  • tection
  • n for

for Re Recr creat ational al. Glo Global bal La Launchpad.

7

  • 1. Jefferies forecast, May 2019

Ke Key y trends im impactin ing the ca canna nnabis is market in in Ca Cana nada.

1.

Setting the standard for global cannabis regulations and fostering early development of competitive cannabis IP.

slide-8
SLIDE 8

8

  • Fo

Focus us group ups across Cana nada

  • Ad

Adult Cannabis Enthusiasts1

  • Average age: 20-30
  • Weekly spend: $120
  • Assess product quality

based on visual inspection and scent

  • 1. Legal Aged Recreational Cannabis Enthusiast Buying Behavior 2018 – Bridgeable.

Exp Experie rience ce-dr driven appr approac

  • ach.

.

Sc Scale Di Discover De Design De Deliver

  • 440,

440,000 000 sq sqft in indoor hybr brid id fa facility

  • Al

All cultivation rooms are e ide identic ical l 10,000 sq sqft ro rooms

  • Pr

Proprietary who hole-pl plan ant dr dry an and d han and-tr trim finish

  • Ag

Agreem eemen ents to sel ell 7AC ACRE RES’ ca cannabis in 8 prov rovince ces

  • Me

Medi dical al di distribution through gh le legacy wh whole lesale le contracts

  • Ad

Advanced ed trade e market eting

  • Inc

Increase sed cul ultivation n sp space fr from 3 rooms to 23 in n 1 year

  • At

At full production capacity, y, an annual al run rat ate of 50,000 kg g

  • Ha

Harvest st e every 3 3 d days o s once ful fully scaled

1.

Ca Case Study

slide-9
SLIDE 9

9

  • Pr

Premium price

  • ce. C$6,000-7,000 per kg
  • Sc
  • Scale. Current run rate of 33,580 kg with full

production run rate of 50,000 kg

  • Te
  • Team. 550+ Employees
  • Br

Bran and d recogn

  • gnition. “Sell-out” strains and

brand asked for by name

  • Mu

Multi aw awar ard-wi winning brand.

1.

slide-10
SLIDE 10

10

Wh Why y pre remiu mium m quality lity ma matte tters rs.

85% 85% of cannabis enthusiasts will not purchase products that have subpar sc scen ent. 63% 63% of cannabis enthusiasts will reject product that does not pass their vi visu sual insp specti tion. Se Sens nsory evalua uation n is used to determine which products will provide desired taste and smoke.

1.

  • 1. Legal Aged Recreational Cannabis Enthusiast Buying Behavior 2018 – Bridgeable.

De Demand d drive ven b by q quality1. .

Myrcene

Limonene

Caryophyllene

Guaiaol

Humulene

alpha-Bisabolol

Beta-Pinene

alpha-Terpineol

Nerolidol

Alpha-Pinene

Isopulegol

Terpinolene

Camphene

Ocimene

+110 cannabinoids, +200 terpenes and hundreds of

  • ther flavonoids, proteins and amino acids.

Infinite chemical combinations determine the spectrum of effects experienced. Terpenes may be

  • ne of the primary drivers of this en

entourage e ef effec ect.

Ef Effec ect driven en by by qua uality.

Known terpenes in 7ACRES’ Sensi Star.

slide-11
SLIDE 11

Pr Protec ection n for prem emium um.

11

*I *In Q4 Q4 2019, 2019, Wappa Wappa st strain wa was added to to th the 7A 7ACRES’ vault for future commercialization **J **Jack Ha Haze was launched in Se September 2019 1.

  • 1. OCS Sales, May 10,

10, 2019 2019

1.

Introducing new strains at higher selling prices.

1.

  • 1. Ov

Oversupply y of low-qu qual ality fl flower. First eight months of legalization, 74% of SKUs sold by the OCS were below C$10 per gram1.

2.

  • 2. In

Increasingly y discerning con

  • nsume

mers. Greater brand-consciousness and willingness to pay premium prices.

3.

  • 3. Est

Establish shed ed market et data in the e U.S. Continued premium pricing for novel strains. 7ACRES 3.5 Gram Retail Price in the OCS

Example: Premium U.S. Strain (USD) Ju Jungle gle Boy’s To Topan panga ga Can anyon $35.30* $35.30 $40.05 $45.60 $49.95**

Wappa White Widow Sensi Star Jean Guy Jack Haze

slide-12
SLIDE 12

12

1.

  • No

Novel ge geneti tics. . Supply agriculturally-focused, disease resistant, premium seed stock

  • Br

Broad applica

  • cation. Recreational, medical and wellness

consumers

  • Ex

Experienced team. Spinoff from 7ACRES genetics business, led by team with +30 years experience of developing plant IP

  • St

State-of

  • f-the

the-ar art f t fac acility ty. . 34,000 sqft research and development facility located in Goderich, Ontario

  • Fo

Foundational IP

  • IP. Creating long-term proprietary value for brands

Cr Creation

  • n and com
  • mmercialization
  • n of
  • f the next

ge generati ation of pr premium can annab abis ge geneti tics.

slide-13
SLIDE 13

10

13

18

Establish fo foundational IP IP and st stron rong core

  • re

bu busin ines esses es. Create di differentiat ated d co consumer-dr driven pr produ duct cts across market segments. Expand consumer- centric approach to in inte ternatio tional l marke kets ts.

1. 1. 2. 2. 3. 3.

slide-14
SLIDE 14

10

14

Cur Current nt offering ings address 86% 86% of the potentia ial l marke ket.

6% 6% C Conc ncent ntrates

Introducing cannabis oils for the wellness consumer Created premium social-use cannabis oils Premium-grade cannabis required for high-quality combustible concentrates

33% 33% F Flo lower

Premium brand delivering high-quality flower in Canada Strain to be developed in Canada based on KKE’s flagship “Khalifa Kush” strain

9% 9% O Othe her

Intends to create topical products for the wellness-oriented consumer Creating oils, capsules, balms and other medicinal products

8% 8% P Pre-ro rolls

Intends to create premium 7ACRES pre-rolls for the Canadian market Premium product lineup is expected to include pre-rolls

30% 30% V Vape

Oil supply agreement and brand partnership with leading vaporizer company To launch premium vaporizer products under KKE brand

Ca Categor

  • ry Mix in Ca

Califor

  • rnia1

13% Edibles 1% Beverages

  • 1. BDS Analytics, March 2019

2.

slide-15
SLIDE 15

10

15

18

2.

  • Est

Establish shed ed wel ellness ess brand. Distributor and retailer in British Columbia producing cannabis oils since August 2018

  • Pr

Proce cessing ca capabiliti

  • ties. Facility with advanced extraction

infrastructure and the capacity to produce over 7,000,000 tincture bottles annually by the end of 2019

  • Se

Serving ng ne new cons nsum umer category. Accelerates growth as a premium wellness-focused cannabis company

slide-16
SLIDE 16

10

16

18

2.

  • Ca

Cannabis derivative products. 5,000 square-foot facility in Scarborough, Ontario will house Supreme Cannabis’ extraction lab for concentrates and vaping liquids

  • In

Internation

  • nal op
  • peration
  • ns. Based in the Netherlands, Truverra’s

European subsidiary delivers CBD Hemp products into the UK and Netherlands, providing an established distribution channel in Europe

  • Glo

Globa bal e l evidenc nce-ba based m medic ical bra l brand. . Address international medical opportunities under the Truverra brand

slide-17
SLIDE 17

17

  • Le

Leading ng premium um brand

  • nd. KKE is a US-based premium

cannabis production and branding company

  • Exc

Exclusi sive ve partner ersh

  • ship. Supreme and KKE entered into

partnership to bring KKE brand and products global

  • Pr

Premium products

  • cts. KKE oils were introduced to the

Canadian market June 2019. Future portfolio to include pre-rolls, flower and derivative products

2.

slide-18
SLIDE 18

18

  • Pr

Premium vaporizer partn

  • tnership. Pax Labs to launch the PAX

Era in Canada with Premium 7ACRES oil pods

  • Est

Establish shed ed partner

  • er. Supreme Cannabis benefits from PAX’s

strong brand recognition, reputation and market leading vaporizer technology, selling more than 500,000 Era devices and over one million devices in the flower vaporizer category

  • He

Health Ca Canada’s New Regulations. Come into effect on October 17, 2019, allowing for 1000mg of THC per package

2.

To Top premi mium um vaporize zer offe ffering ng in n Cana nada.

slide-19
SLIDE 19

10

19

18

Establish fo foundational IP IP and st stron rong core

  • re

bu busin ines esses es. Create di differentiat ated d co consumer-dr driven pr produ duct cts across market segments. Expand consumer- centric approach to in inte ternatio tional l marke kets ts.

1. 1. 2. 2. 3. 3.

slide-20
SLIDE 20

10

20

3.

10

Can Canadi adian an bor

  • rn.

Gl Glob

  • bally focu
  • cused

ed.

slide-21
SLIDE 21

10

21

18

  • St

Strategic inv nvestment

  • nt. Global distribution

agreement and 10% equity interest

  • De

Desirable cultivation location. Located in the Kingdom of Lesotho, a jurisdiction located within Southern Africa

  • In

Internation

  • nal me

medical Foc

  • cus. Medical cannabis oil

products for international markets

  • Ad

Advanced facility.

  • y. Completing EU GMP facility,

400+ current employees and 424,000 sqft of cultivation across 8 pads

3.

slide-22
SLIDE 22

10

22

18

  • Si

Signe ned LOI LOI with h Malta Ent

  • nterprise. One of the first

companies to secure an LOI with Malta, the first step in applying for a Cannabis Production License

  • St

Strategic hub hub for Eur

  • urope. Deliver high-quality

cannabis products to medical patients in multiple international markets

  • Lo

Local expertise. Robust pharmaceutical and nutraceutical manufacturing industries

3.

slide-23
SLIDE 23

10

23

18

  • In

Investme ment platfor

  • rm.
  • m. Supreme Heights is a separate entity

that is solely addressing opportunities in the UK and Europe’s CBD health and wellness market

  • CBD

CBD offerings. Targeting investments in wellness brands with CBD offerings in vaporizers, topicals, edibles and beverages

  • r with ancillary services
  • St

Strong ng partne nershi

  • hip. Supreme Cannabis’ to contribute regulatory,

product commercialization, supply chain, marketing and capital markets expertise and corporate support services

3.

slide-24
SLIDE 24

24

Exe Execu cution tional l exce xcelle llence ce.

$1.6 $1.7 $2.1 3.5

$5.1 $7.7 $10.0 $19.0

Q1 Q2 Q3 Q4

FY2018 FY2019

1 For the quarter ended June 30, 2019

RANKS 6TH FOR CANADIAN LP REVENUE RUN RATE1

Net Revenue Growth

($ millions)

slide-25
SLIDE 25

25

SUPREME QUICK FACTS

Christopher Carey Tamy Chen Matthew Bottomley Jesse Pytlak Graeme Kreindler Robert Fagan Jason Zandberg REVENUE (LFQ) $19 million REVENUE (LTM) $44 million CASH $55 million MARKET CAP $457 million SHARES O/S 302 million WARRANTS, OPTIONS AND CONVERTIBLE DEBT 114 million FULLY DILUTED SHARES O/S 416 million

ANALYST COVERAGE

(June 30, 2019)

slide-26
SLIDE 26

26

Exp Experie rience ced le leaders rship ip.

NI NIKHIL HAND ANDA

CHIEF FINANCIAL OFFICER

NAV NAVDEEP DH DHALIWAL*

CHIEF EXECUTIVE OFFICER

JO JOHN FO FOWLER*

CHIEF ADVOCACY OFFICER AND FOUNDER

RI RIYAZ AZ LA LALA LANI

CHIEF CORPORATE OFFICER

*Executive also serves as a member of the board

Over a decade in the medical cannabis sector as a cultivator, influencer, patients- rights advocate and lawyer

Vice Chair, Adult Use, and a Director of the Cannabis Council of Canada

Founded Supreme Cannabis’ wholly-owned subsidiary 7ACRES in 2013

Previously, corporate and securities lawyer at Torkin Manes LLP

Entrepreneur, financier and investor focused on ventures and initiatives that create positive global change

Director of Medigrow Lesotho, a Licensed Producer in the Kingdom of Lesotho

Previously, principal of NLX Capital Corp., a Canadian merchant bank and venture investment firm

Previously, Vice President of corporate development for Novalux Energy Corporation

Manages capital allocation planning, M&A, and transactional execution

Previously, Vice President of Finance at Well.ca, a leading

  • nline destination for health,

and wellness products

Previously held senior finance and operational roles at Restaurant Brands International

Previously, vice president of mergers and acquisition group at RBC Capital Markets

Specializes in financial transactions, shareholder actions, crisis communications and media relations.

Founded leading communications and stakeholder relations firm Bayfield Strategy, Inc.,

Previously, Chief Operating Officer of Canada’s largest proxy firm, Kingsdale Shareholder Services

Director of the Canadian Journalism Foundation and a past director of three public companies

SO SONY NY GOKHALE

GENERAL COUNSEL

Skilled legal professional with extensive experience launching new products and services in regulated and non-regulated companies

Previously, senior member of the Commercial and Technology group at Osler, Hoskin & Harcourt, LLP

Previously, member of BlackBerry’s legal group and prior to BlackBerry, practiced at Davis LLP

slide-27
SLIDE 27

27

Stron Strong Corp Corpora

  • rate

te Gove

  • vern

rnance ce.

DI DIMITRE NAO NAOUMOV

VP FINANCE

Exte Extended Le Leaders rship ip Team. m.

NI NIKHIL HAND ANDA

CHIEF FINANCIAL OFFICER

CO COLI LIN MO MOORE

DIRECTOR OF THE BOARD

RO RON N FA FACTOR

DIRECTOR OF THE BOARD

SO SONY NY GO GOKHALE

GENERAL COUNSEL

OM OMER AZ AZEEZ

VP COMMERCIALIZATION

RAM RAM DAV AVLOOR

SENIOR VP, OPERATIONS

MI MICHAEL LA LA BR BRIER

CHAIRMAN OF THE BOARD

ST STEVE CH CHAN

VP CORPORATE AFFAIRS & CORPORATE SECRETARY

BA BARINDER BH BHULLAR VP INTERNATIONAL AFFAIRS

& STAKEHOLDER RELATIONS

KE KEN MCKI KINNON

DIRECTOR OF THE BOARD

NAV NAVDEEP DH DHALIWAL*

CHIEF EXECUTIVE OFFICER

JO JOHN FO FOWLER

CHIEF ADVOCACY OFFICER & FOUNDER

CHA CHANG PARK

VP GROWTH OPPORTUNITIES

AS ASH RAJ RAJEND NDRA RA

CHIEF INFORMATION OFFICER

RI RIYAZ AZ LA LALA LANI

CHIEF CORPORATE OFFICER

*Executive also serves as a member of the board

NI NICOLE SAL ALE

VP COMMUNICATIONS AND INVESTOR RELATIONS

VA VALERIE ROTH THER

VP TALENT

TA TAR DEOL

VP INFRASTRUCTURE

slide-28
SLIDE 28

$F $FIRE

The Supreme Cannabis Company TS TSX X : FIRE Madelin Daviau, Investor Relations Email: ir@supreme.ca Phone: 416-466-6265 Supreme.ca The Supreme Cannabis Company TheSupremeFIRE TheSupremeFIRE

28

slide-29
SLIDE 29